Items Tagged ‘Individualizing Medicine Conference 2019’
August 15, 2019
Shaping the landscape of cancer care with precision therapies
By Sharon Rosen 
Article by Sara Damore Jeffrey Tyner, Ph.D., associate professor in the Department of Cell & Developmental Biology at Oregon Health & Science University, will join several precision cancer care leaders from across the country at the annual Individualizing Medicine Conference. Dr. Tyner will present “Precision Therapy through Functional Genomics in Hematologic Malignancies.” Dr. Tyner’s research […]
Tags: #acute myeloid leukemia, #CIMCon19, #Dr. Jeffrey Tyner, #Functional Genomics, #targeted therapies, blood cancers, center for individualized medicine, genomics, hematolgic malignancies, Individualizing Medicine Conference 2019, mayo clinic, Oregon Health and Science University
July 18, 2019
Targeting therapy to each patient’s unique cancer
By Sharon Rosen
Article by Sara Damore As DNA sequencing technology helps bring genetic factors driving disease into focus, researchers have developed new cancer therapies to target a patient’s unique cancer, especially for those who do not respond to standard therapy. Funda Meric-Bernstam, M.D., a physician-scientist at MD Anderson Cancer Center will speak on Decision Support for Precision […]
Tags: #CIMCon19, #Mayo Cllinic, breast cancer, center for individualized medicine, Dr. Alan Bryce, Dr. Funda Meric-Bernstam, Genetic Sequencing, Genetic Testing, Individualizing Medicine Conference 2019, lymphoma, MD Anderson, Melanoma
May 29, 2019
By Sharon Rosen
Amidst the demands of providing care for patients with cancer, it can be challenging for oncologists and their care teams to keep up with the rapidly evolving field of genomics. Practical ways to apply the latest precision medicine discoveries is the focus of this year’s Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics, […]
Tags: #CAR T-cell therapy, #CIMCon19, biliary cancer, breast cancer, center for individualized medicine, Dr. Alan Bryce, familial cancer syndromes, hematologic cancers, immunotherapies, Individualizing Medicine Conference 2019, Lung Cancer, lymphoma